Investor News & Updates

two people talking in front of bayer logo

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 428 News
1 - 10of 428 News
June 30, 2025
U.S. Supreme Court asks for views of Solicitor General in Durnell case
READ MORE
June 27, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg with extended 6-month treatment interval approved in the EU
READ MORE
June 20, 2025
Not intended for U.S. and UK Media
CHMP recommends third indication for Bayer’s Nubeqa™ (darolutamide) for patients with advanced prostate cancer
READ MORE
June 17, 2025
Not intended for US and UK Media
Bayer files for approval of gadoquatrane in the U.S.
READ MORE
June 05, 2025
Not intended for U.S. and UK Media – CONFIDENCE Phase II study results presented at 62nd ERA Congress:
Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes
READ MORE
June 03, 2025
Not intended for U.S. and UK Media
U.S. FDA approves third indication of Bayer blockbuster Nubeqa™ (darolutamide) for patients with advanced prostate cancer
READ MORE
June 02, 2025
Not intended for UK Media – Data from Phase III OASIS-4 study to be presented for the first time at 2025 ASCO Annual Meeting:
Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study
READ MORE
June 02, 2025
Not intended for U.S. and UK Media
Gadoquatrane submitted for marketing authorization in Japan
READ MORE
May 28, 2025
Not intended for U.S. and UK Media
Sevabertinib (BAY 2927088) granted FDA Priority Review for the treatment of patients with HER2-mutant non-small cell lung cancer
READ MORE
May 23, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg with extended 6-month treatment interval recommended for approval in EU
READ MORE
1 - 10of 428 News
1 - 10of 428 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more